Bashir Shihabuddin

Professor

UAMS primary UA Little Rock

Also affiliated: University of Maryland, Baltimore (2007); Vanderbilt University (2006); University of Arkansas Medical Center (2007–2017); Saint George Hospital (2013); Central Arkansas Veterans Healthcare System (2014–2021); Vanderbilt University Medical Center (1999–2001)

Faculty Researcher

Neurology, College of Medicine

8 h-index 20 pubs 214 cited

Research Areas

Biomedical Subjects

Links

Research Group UAMS TRI Profile

OverviewAI-generated summary

Bashir Shihabuddin's research focuses on the study of neurological disorders, particularly in relation to electroencephalography (EEG) and magnetoencephalography (MEG). He has investigated autoimmune encephalitis and its association with seizures, examining findings from cerebrospinal fluid, imaging, and EEG. His work also explores the relationship between changes in EEG activity and a decrease in tinnitus awareness following repetitive transcranial magnetic stimulation (rTMS). Shihabuddin has published 20 papers, accumulating 200 citations, and holds an h-index of 8. He collaborates with researchers at the University of Arkansas for Medical Sciences, including Abdallah Hayar, John L. Dornhoffer, Kalpana P. Padala, and Edgar García‐Rill. His recent activity indicates ongoing engagement in his field.

Metrics

h-index: 8
Publications: 20
Citations: 214

Selected Publications

Autoimmune encephalitis and seizures, cerebrospinal fluid, imaging, and EEG findings: a case series (2021)

Neurological Sciences 14 citations DOI OpenAlex
Change in EEG Activity is Associated with a Decrease in Tinnitus Awareness after rTMS. (2021)

PubMed 6 citations OpenAlex
Predictive Value of Electrocorticography in Patients With Mesial Temporal Lobe Epilepsy Undergoing Selective Amygdalohippocampectomy (2017)

Journal of Clinical Neurophysiology 5 citations DOI OpenAlex
Seizures in Subdural Hematoma (2015)

1 citation DOI OpenAlex
The Predictive Value of Electrocorticography in Patients with Mesial Temporal Lobe Epilepsy Undergoing Selective Amygdalohippocampectomy (P6.340) (2014)

Neurology DOI OpenAlex
Ictal asystole in epilepsy patients undergoing inpatient video-EEG monitoring (2014)

Neurosciences 5 citations DOI OpenAlex
Methadone induced Torsades de Pointes mimicking seizures in clinical presentation (2014)

The American Journal of Drug and Alcohol Abuse 6 citations DOI OpenAlex
Episodic nausea and abdominal sensations as sole manifestations of simple partial seizures (2007)

Neurosciences 6 citations DOI OpenAlex
Non-invasive detection and identification of brain activity patterns in the developing fetus (2007)

Clinical Neurophysiology 58 citations DOI OpenAlex
FC25.1 Non-invasive measurement of spontaneous fetal brain activity using magnetoencephalography (2006)

Clinical Neurophysiology DOI OpenAlex
Magnetoencephalography in healthy neonates (2006)

Clinical Neurophysiology 17 citations DOI OpenAlex

View all publications on OpenAlex →

Grants & Funding

As listed on this researcher's institutional profile.

An International, double-blind, randomized, multi-center, parallel group, historical-control conversion to monotherapy study to evaluate the efficacy UCB BioSciences, Inc. Principal Investigator
RII Track-2 FEC- Probing and Understanding the Brain: Micro and Macro Dynamics of Seizure and Memory Networks - Continuation - Continuation - Continuation National Science Foundation via Louisiana Tech University Co-Investigator
SP0982 UCB BioSciences, Inc. Principal Investigator
Multicenter, Double-Blind, Randomized, Placebo-Controlled, Three-Arm, Parallel Group Study to Evaluate the Efficacy and Safety of Oxcarbazepine Extend Supernus Pharmaceuticals, Inc. Principal Investigator
Multicenter, Open-Label Extension Study to Evaluate the Long-Term Safety and Tolerability of Oxcarbazepine Extended-Release (OXC XR) as Adjunctive The Supernus Pharmaceuticals, Inc. Principal Investigator
A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP, MULTI-CENTER TRIAL OF PREGABALIN CR AS ADJUNCTIVE THERAPY IN ADULT PATIENTS WITH PARTI Pfizer, Inc. Principal Investigator
Prospective Randomized 12-Weeks Controlled Study of Visual Field Change in Subjects with Partial Seizures Receiving Pregabalin of Placebo Pfizer, Inc. Principal Investigator
Development of Analysis Tools to Enhance Fetal Neurological Assessment NIH Co-Investigator

Double-Blind, Randomized, Historical Control Study of the Safety and Efficacy of Eslicarbazepine Acetate Monotherapy in Subjects with Partial Epilepsy Sunovion Pharmaceuticals, Inc. Principal Investigator
A 14 Month Open-label Extension Phase of the Double-blind, Placebo Controlled Dose Escalation Parallel Group Study of E2007 as Adjunctive Therapy in P Eisai Principal Investigator
RTG116158 GlaxoSmithKline Principal Investigator
Protocol E2007-G000-332: A Double-blind, Randomized, Placebo-controlled, Multicenter, Parallel-group Study with an Open-label Extension Phase to Evalu Eisai Principal Investigator
“An open label study to evaluate the effects of ezogabine/retigabine added to exi GlaxoSmithKline Principal Investigator
CTA-Sunovion 093-050 Long Term Eslicarbazepine Acetate Extension Study. Sunovion Pharmaceuticals, Inc. Principal Investigator
An open-label, multinational, multicenter, follow-up study to evaluate the long-term safety and efficacy of brivaracetam used at a flexible dose up to UCB BioSciences, Inc. Principal Investigator
Fetal Magnetoencephalography and Evoked Potentials NIH Co-Investigator